![]() |
||
![]() |
||
|
MedWatch Updates 34 Product Safety Labels
By Doug Beardsley The MedWatch September 2011 safety labeling changes posting included 34 products with safety labeling changes to the following sections: boxed warnings, contraindications, warnings, precautions, adverse reactions, patient package insert, and medication guide. The "Summary Page" provides a listing of drug names and safety labeling sections that were revised: http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm274280.htm. Clicking on a drug product name in the summary view will take you to the "detailed view" page, which identifies the safety labeling sections and subsections revised, along with a brief summary of new or modified safety information. The following drugs had modifications to the boxed warnings, contraindications and warnings sections: Detrol (tolterodine tartrate) tablets and Detrol LA (tolterodine tartrate) extended release tablets Doug Beardsley |
Resources | |
|
||
To ensure delivery of communications, please add 'info@careproviders.org' to your email address book.
If you are still having problems receiving our emails, see our whitelisting page for more details:
http://www.commpartners.com/website/white-listing.htm